Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1993-5-13
pubmed:abstractText
1. Rats were anaesthetized with sodium pentobarbitone and maximal twitches of a tibialis anterior muscle were evoked by stimulation of the motor nerve. 2. Suramin, injected intravenously in a series of cumulative bolus doses, each 15 mg kg-1, completely reversed a 90% depression of twitches maintained by a continuous intravenous infusion of pancuronium. The cumulated dose necessary to restore twitches to 50% of their control amplitude was 35 mg kg-1. Suramin did not modify a similar degree of block produced by suxamethonium, nor did it affect the amplitude of control maximal twitches, even in cumulative doses up to 150 mg kg-1. 3. The effects of bolus doses of suramin (85 mg kg-1), neostigmine (0.03 mg kg-1) and 4-aminopyridine (1.2 mg kg-1), calculated to restore pancuronium-blocked twitches to 95% of control amplitude, were compared. Suramin produced the most rapid reversal (1.1 +/- 0.5 min), but its duration of action was the shortest (9.4 +/- 1.6 min). Suramin was without effect on heart rate or blood pressure in the doses used. 4. The results showed that suramin reversed neuromuscular block produced by nondepolarizing blocking drug, pancuronium, but was without effect on a block produced by the depolarizing blocking drug, suxamethonium. Its short duration of action suggests that suramin would probably not be of value clinically as a reversal agent. However, it is possible that it might serve as a starter compound for the synthesis and development of a new class of reversal agents for use in anaesthetic practice.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-1326440, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-1393284, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-166162, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-1690710, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-2076483, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-2291521, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-2291532, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-2806375, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-2926472, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-3013455, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-3359103, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-3814919, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-4355468, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-6304532, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-6529978, http://linkedlifedata.com/resource/pubmed/commentcorrection/8467359-7248118
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
717-20
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Reversal by suramin of neuromuscular block produced by pancuronium in the anaesthetized rat.
pubmed:affiliation
Department of Pharmacology/Clinical Pharmacology, University of Groningen, The Netherlands.
pubmed:publicationType
Journal Article